^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CC-3
i
Other names: CC-3
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
German Cancer Research Center, University of Tuebingen
Drug class:
CD3 agonist, B7-H3 inhibitor
Related drugs:
Phase 1
German Cancer Research Center
Recruiting
Last update posted :
02/26/2024
Initiation :
01/12/2024
Primary completion :
10/30/2026
Completion :
03/31/2027
BRAF
|
MSI-H/dMMR • BRAF V600 • RAS wild-type
|
CC-3
Share
